n(6)-carboxymethyllysine has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Castillo, A; Gallardo, M; Landy, DC; Livingstone, A; Manning, R; Namias, N; Schulman, CI; Striker, GE; Uribarri, J; Vlassara, H | 1 |
| Borggrefe, M; Brueckmann, M; Hammes, HP; Kälsch, T; Kralev, S; Lang, S; Lin, J; Rippert, A; Süselbeck, T; Zimmerer, E | 1 |
2 other study(ies) available for n(6)-carboxymethyllysine and Acute Disease
| Article | Year |
|---|---|
Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.
Topics: Acute Disease; Adult; Female; Glycation End Products, Advanced; Humans; Intensive Care Units; Kinetics; Longitudinal Studies; Lysine; Male; Middle Aged; Pyruvaldehyde; Severity of Illness Index; Wounds and Injuries | 2014 |
Elevation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in patients presenting with acute myocardial infarction.
Topics: Acute Disease; Aged; Female; Glycosides; Humans; Lysine; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction | 2009 |